YOUNG JAMES EMMETT (Chief Financial Officer) purchased 24K shares of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $129.6K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/29/2025ACC: 0001415889-25-002287
Officer· Chief Financial Officer
Since Jan 2025
+111.50K
Net shares
Net buyer
$129.6K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
111.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.50K
Price / share
—
Trade value
—
% of position
135.5%
1/27/2025
9.23K→21.73K
Common Stock
Indirect
Shares
+24K
Price / share
$5.40
Trade value
$129.60K
% of position
New position
1/27/2025
0.00→24K
Total
Net shares
+36.50K
Net value
$129.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2025 | A · Award | +12.50K | — | — | 135.5% | 9.23K | 21.73K |
| Common Stock Indirect | 1/27/2025 | P · Purchase | +24K | $5.40 | $129.60K | New position | 0.00 | 24K |
| Total | +36.50K | $129.60K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
75K shares
Shares
+75K
Strike price
5.30
Held after
75K
Exercisable
—
1/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock75K shares | 1/27/2025 | A · Award | +75K | 5.30 | — | 75K |